Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.

Cancer chemotherapy and pharmacology - 1 Sept 2016

Kim Jeong-Hyun, Lee Chansu, Cheong Hyun Sub, Koh Youngil, Ahn Kwang-Sung, Kim Hyung-Lae, Shin Hyoung Doo, Yoon Sung-Soo

Abstract excerpt

PURPOSE: The solute carrier family 29 (equilibrative nucleoside transporter), member 1 (SLC29A1) is known to be involved in the transportation and resistance of the nucleoside analog cytosine arabinoside (AraC), one of the most effective drugs in the treatment of acute myeloid leukemia (AML). METHODS: In vitro functional analysis in AML cells and genetic association study were performed. RESULTS: Our functional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytarabine

Share to Genetic Association Studies

Share to Leukemia, Myeloid, Acute

Share to Remission Induction

Share to Treatment Outcome

Share to Young Adult

Source

Identifiers

PMID: 27422302
DOI: 10.1007/s00280-016-3103-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.PMID 27422302Read ↗

SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study.Semantic proximity Read ↗

Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy.Semantic proximity Read ↗

NT5C3 polymorphisms and outcome of first induction chemotherapy in acute myeloid leukemia.Semantic proximity Read ↗

Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients.Semantic proximity Read ↗

RNA Expression of Genes Involved in Cytarabine Metabolism and Transport Predicts Cytarabine Response in Acute Myeloid LeukemiaSemantic proximity Read ↗

OCTN1 Is a High-Affinity Carrier of Nucleoside AnaloguesSemantic proximity Read ↗

Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.Semantic proximity Read ↗

Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML).Semantic proximity Read ↗

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.Semantic proximity Read ↗

DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid LeukemiaSemantic proximity Read ↗

Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell LinesSemantic proximity Read ↗

Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.